Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

11.07.2025 09:00AM
Study issued by NuWays AG

Cantourage Group SE (von NuWays AG): BUY

BUY
Company Name: Cantourage Group SE ISIN: DE000A3DSV01   Reason for the research: Update Recommendation: BUY from: 11.07.2025 Target price: EUR 13.00 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr CEO’s temporary leave with no impact on operations. CEO Philip Schetter has informed the s [ … ]
09.07.2025 09:56AM

Energiekontor AG (von First Berlin Equity Research GmbH): Buy

Buy
Company Name: Energiekontor AG ISIN: DE0005313506   Reason for the research: Update Recommendation: Buy from: 09.07.2025 Target price: 105,00 Euro Target price on sight of: 12 Monate Last rating change: 18.10.2022: Hochstufung von Hinzufügen auf Kaufen Analyst: Dr. Karsten von Blumenthal First Berlin Equity Research hat ein [ … ]
08.07.2025 08:43AM
Study issued by GBC AG

Avemio AG (von GBC AG): BUY

BUY
Company Name: Avemio AG ISIN: DE000A40KY59   Reason for the research: Research study (Anno) Recommendation: BUY Target price: 15.00 EUR Target price on sight of: 31.12.2025 Last rating change: Analyst: Cosmin Filker; Niklas Ripplinger You can download the research here: 20250707_Avemio_Anno_engl Contact for questions: GBC AGHa [ … ]
07.07.2025 05:45PM

Vossloh AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy

Buy
Company Name: Vossloh AG ISIN: DE0007667107   Reason for the research: Update Recommendation: Buy from: 07.07.2025 Target price: 102 Last rating change: Analyst: Daniel Kukalj, CIIA,CEFA Driving Infrastructure Growth Following a change of analyst, we are raising our price target to EUR 102, applied by our ROE/COE valuation approa [ … ]
07.07.2025 09:00AM
Study issued by NuWays AG

MHP Hotel AG (von NuWays AG): Buy

Buy
Company Name: MHP Hotel AG ISIN: DE000A3E5C24   Reason for the research: Update Recommendation: Buy from: 07.07.2025 Target price: EUR 3.00 Target price on sight of: 12 months Last rating change: Analyst: Philipp Sennewald Successful cap hike paves to way for portfolio expansion MHP has successfully completed the announced capit [ … ]
02.07.2025 11:30AM
Study issued by GBC AG

Verve Group SE (von GBC AG): BUY

BUY
Company Name: Verve Group SE ISIN: SE0018538068   Reason for the research: Research study (Anno) Recommendation: BUY Target price: 9.20 EUR Last rating change: Analyst: Marcel Goldmann, Cosmin Filker Verve also achieved a significant increase in revenue of 32.2% to € 109.04 million in the first quarter of the current financ [ … ]
01.07.2025 09:01AM
Study issued by NuWays AG

ZEAL Network SE (von NuWays AG): BUY

BUY
Company Name: ZEAL Network SE ISIN: DE000ZEAL241   Reason for the research: Update Recommendation: BUY Target price: EUR 64.00 Target price on sight of: 12 months Last rating change: Analyst: Henry Wendisch Q2 lottery spending remains at high levels Yesterday, we analyzed the Q2 lottery data published by the DLTB (German state lo [ … ]
30.06.2025 01:22PM

ParTec AG (von First Berlin Equity Research GmbH): Under Review

Under Review
Company Name: ParTec AG ISIN: DE000A3E5A34   Reason for the research: Update Recommendation: Under Review from: 30.06.2025 Target price: Under Review Target price on sight of: 12 months Last rating change: 30.06.2025 (previously: Buy) Analyst: Simon Scholes First Berlin Equity Research has published a research update on ParTec A [ … ]
30.06.2025 12:51PM

Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy

Buy
Company Name: Marinomed Biotech AG ISIN: ATMARINOMED6   Reason for the research: Initiation of coverage Recommendation: Buy from: 30.06.2025 Target price: 50,00 Euro Target price on sight of: 12 months Last rating change: - Analyst: Alexander Rihane First Berlin Equity Research hat am 30.06.2025 die Coverage von Marinomed Biotec [ … ]
30.06.2025 08:00AM
Study issued by GBC AG

Samara Asset Group PLC (von GBC AG): Buy

Buy
Company Name: Samara Asset Group PLC ISIN: MT0001770107   Reason for the research: Research Comment Recommendation: Buy Target price: 3.93 EUR Target price on sight of: 31.12.2026 Last rating change: Analyst: Matthias Greiffenberger, Cosmin Filker The platform has already attracted strategic capital. A recent financing round le [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL